Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
Okay, this comment thread has convinced me that almost noone here actually reads anything but the headline. I think I’m gonna resign from Lemmy too… Is there somewhere online where intelligent adults have conversations?